On Cell And Gene Therapies, Payers And Providers Should Collaborate To Enhance Access And Affordability William H. Shrank,Daniel Knecht,Harlan Levine,andJaewon Ryu August 6, 2026

https://www.healthaffairs.org/content/forefront/cell-and-gene-therapies-payers-and-providers-should-collaborate-enhance-access-and The advent of cell and gene therapies heralds a powerful shift, but without deliberate attention to financing, delivery, data, and equity, practice will not meet the promise of this transformative science.